PHILADELPHIA – Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a study presented today by Penn Medicine researchers at ENDO, The Endocrine Society'
... Читать дальше »
Jun 10, 2009 (Datamonitor via COMTEX) -- US-based Keryx Biopharmaceuticals has reported positive results of the Phase II study of Zerenex for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on thrice weekly hemodialysis.
The study was a multicenter, open-label clinical trial, which enrolled 55 patients. The primary objective of this study was to assess the tolerability and safety of Zerenex (ferric citrate) with doses ranging from approximately 1gm per day to 12gm per
... Читать дальше »
